(Total Views: 295)
Posted On: 10/22/2018 4:09:07 PM
Post# of 721
NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Has Filed New Patent Application in Strategic Effort to Build Global Portfolio
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), in a strategic effort to build its global intellectual property (IP) portfolio, has filed a new patent application for its proprietary absorption technology platform. An article discussing this reads, “It has filed a provisional application in a tenth patent family relating to the applicability of DehydraTECH’s imparting benefits to tobacco leaves to deliver compounds that may or may not include nicotine. That patent family is ‘Lipophilic Active Agent Infused Tobacco Leaves and/or Tobacco Materials and Methods of Use Thereof.’”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), in a strategic effort to build its global intellectual property (IP) portfolio, has filed a new patent application for its proprietary absorption technology platform. An article discussing this reads, “It has filed a provisional application in a tenth patent family relating to the applicability of DehydraTECH’s imparting benefits to tobacco leaves to deliver compounds that may or may not include nicotine. That patent family is ‘Lipophilic Active Agent Infused Tobacco Leaves and/or Tobacco Materials and Methods of Use Thereof.’”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
